So far, studies have shown SIRT1 can have both a tumor-suppressor and a tumor-promoter effect depending on its predominant localization—cytoplasmatic versus nuclear—or on the cell type on which is overexpressed, normal hepatocytes versus HCC cells [83]. This evidence concerns the gene SIRT1 and neoplasm.